Day One Biopharmaceuticals Stock Alpha and Beta Analysis
| DAWN Stock | USD 11.95 0.39 3.16% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Day One Biopharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Day One over a specified time horizon. Remember, high Day One's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Day One's market risk premium analysis include:
Beta 0.64 | Alpha 0.88 | Risk 6.93 | Sharpe Ratio 0.14 | Expected Return 0.98 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Day One Backtesting, Day One Valuation, Day One Correlation, Day One Hype Analysis, Day One Volatility, Day One History and analyze Day One Performance. Day One Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Day One market risk premium is the additional return an investor will receive from holding Day One long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Day One. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Day One's performance over market.| α | 0.88 | β | 0.64 |
Day One expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Day One's Buy-and-hold return. Our buy-and-hold chart shows how Day One performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Day One Market Price Analysis
Market price analysis indicators help investors to evaluate how Day One stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Day One shares will generate the highest return on investment. By understating and applying Day One stock market price indicators, traders can identify Day One position entry and exit signals to maximize returns.
Day One Return and Market Media
The median price of Day One for the period between Sat, Oct 25, 2025 and Fri, Jan 23, 2026 is 8.85 with a coefficient of variation of 14.0. The daily time series for the period is distributed with a sample standard deviation of 1.26, arithmetic mean of 9.01, and mean deviation of 0.97. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Day One Biopharmaceuticals, Inc. Reports Q3 Loss, Tops Revenue Estimates | 11/04/2025 |
2 | Disposition of 3570 shares by Bender Jeremy of Day One subject to Rule 16b-3 | 11/14/2025 |
3 | Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference | 11/18/2025 |
4 | Acquisition by Bender Jeremy of 300000 shares of Day One subject to Rule 16b-3 | 11/26/2025 |
5 | Man found guilty of murdering wife after child reveals new evidence in rare retrial | 12/12/2025 |
6 | Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference | 12/16/2025 |
7 | DAWN raises 13M to expand decentralized broadband networks | 12/18/2025 |
8 | Day One Completes Acquisition of Mersana Therapeutics | 01/06/2026 |
9 | Day One Biopharmaceuticals Surges 26.7 percent Is This an Indication of Further Gains | 01/13/2026 |
10 | Wall Street Analysts Think Day One Biopharmaceuticals Could Surge 107.36 percent Read This Before Placing a Bet | 01/15/2026 |
11 | First Week of March 20th Options Trading For Day One Biopharmaceuticals - Nasdaq | 01/16/2026 |
12 | Assessing Day One Biopharmaceuticals Valuation After Strong OJEMDA Revenue Update And 2026 Growth Outlook | 01/22/2026 |
About Day One Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Day or other stocks. Alpha measures the amount that position in Day One Biopharmaceu has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Payables Turnover | 1.46 | 0.75 | Days Of Inventory On Hand | 206.66 | 183.7 |
Day One Upcoming Company Events
As portrayed in its financial statements, the presentation of Day One's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Day One's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Day One's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Day One. Please utilize our Beneish M Score to check the likelihood of Day One's management manipulating its earnings.
| 4th of March 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Day One
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Day One Backtesting, Day One Valuation, Day One Correlation, Day One Hype Analysis, Day One Volatility, Day One History and analyze Day One Performance. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Day One technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.